NABI /DE/
424B3, 1997-06-17
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORP /DC/, 424B3, 1997-06-17
Next: ORANGE & ROCKLAND UTILITIES INC, 8-K, 1997-06-17



<PAGE>   1
                                                Filed pursuant to Rule 424(b)(3)
                                                       Registration No. 333-2253
PROSPECTUS SUPPLEMENT
To Prospectus Dated May 3, 1996,
As Supplemented to Date


                                  $80,500,000


                                      NABI


                 6 1/2% Convertible Subordinated Notes due 2003
                                      and
               Shares of Common Stock, Par Value $.10 Per Share,
                        Issuable Upon Conversion Thereof


     This Prospectus Supplement (the "Supplement") relates to the resale by Van
Kasper & Company ("Van Kasper") of up to $200,000 aggregate principal amount of
6 1/2% Convertible Subordinated Notes due 2003 (the "Notes") of NABI, a Delaware
corporation (the "Company"), originally issued in private placements
consummated on February 7 and March 6, 1996 (the "Debt Offering"), pursuant to
NABI's Registration Statement on Form S-3 (No. 333-2253) (the "Registration
Statement"). This Supplement should be read in conjunction with the Prospectus
dated May 3, 1996, as supplemented to date (the "Prospectus"), to be delivered
with this Supplement. All capitalized terms used but not defined in this
Supplement shall have the meanings given them in the Prospectus.

     Based on information provided to the Company, the aggregate principal
amount of the Notes that are currently beneficially owned by Van Kasper is
$200,000, all of which may be sold at this time pursuant to the Prospectus as
supplemented hereby. Additional information concerning the Selling
Securityholders (including Forum) may be set forth from time to time in
additional supplements to the Prospectus. The total outstanding aggregate
principal amount of the Notes is $80,500,000.

     The closing price of the Company's Common Stock as reported on The Nasdaq
National Market on June 6, 1997 was $7.25 per share.

     The Notes will be subordinated to all existing and future Senior
Indebtedness of the Company. At December 31, 1996, Senior Indebtedness was
approximately $2,400,000. The Indenture contains no limitations on the
incurrence of additional indebtedness or other liabilities by the Company.

     The Notes are neither listed on a national securities exchange nor quoted
on an automated quotation system. However, the Notes are eligible for trading
in the Private Offerings, Resales and Trading through Automated Linkages
("PORTAL") Market. Notes sold pursuant to the Registration Statement will no
longer be eligible for trading in the PORTAL Market.

            The date of this Prospectus Supplement is June 9, 1997.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission